Carrie L. Bourdow

Insider Reports History

Location
King Of Prussia, PA
Signature
/s/ Jennifer Keyser, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Carrie L. Bourdow:

Company Role Class Num Shares Value Price $ Report Date Ownership
TREVENA INC Acting CEO, Director Common Stock 23,894 $35,124 $1.47 08 Oct 2024 Direct
Sesen Bio, Inc. Director Common Stock 40,000 $23,480 $0.5870 22 Jun 2022 Direct
Nabriva Therapeutics plc Director Ordinary Shares 9,933 $14,900 $1.50 01 Aug 2022 Direct
Sesen Bio, Inc. Director Stock Option 65,000 22 Jun 2022 Direct

Insider Reports Filed by Carrie L. Bourdow

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TRVN TREVENA INC 08 Oct 2024 5 -$2,678 4 Acting CEO, Director 10 Oct 2024, 17:07
TRVN TREVENA INC 14 Dec 2023 3 +$282,355 4 President & CEO 15 Dec 2023, 18:57
TRVN TREVENA INC 02 Dec 2023 3 -$7,097 4 President & CEO 05 Dec 2023, 17:51
TRVN TREVENA INC 06 Jan 2023 1 $0 4 President & CEO, Director 06 Jan 2023, 16:52
TRVN TREVENA INC 17 Dec 2022 1 -$2,080 4 President & CEO 20 Dec 2022, 15:33
TRVN TREVENA INC 02 Dec 2022 1 -$12,175 4 President & CEO, Director 06 Dec 2022, 15:32
/report/000110465922085789-bourdow-carrie-l-2022-08-01 Nabriva Therapeutics plc 01 Aug 2022 1 -$1,487 4 Director 03 Aug 2022, 21:47
CARM Sesen Bio, Inc. 22 Jun 2022 2 $0 4 Director 24 Jun 2022, 18:28
TRVN TREVENA INC 17 Dec 2021 1 -$23,482 4 President & CEO, Director 21 Dec 2021, 15:17
TRVN TREVENA INC 06 Dec 2021 1 -$60,815 4 President & CEO, Director 08 Dec 2021, 15:16
TRVN TREVENA INC 02 Dec 2021 1 $0 4 President & CEO, Director 03 Dec 2021, 15:59
/report/000110465921100287-bourdow-carrie-l-2021-08-02 Nabriva Therapeutics plc 02 Aug 2021 1 -$932 4 Director 04 Aug 2021, 21:04
/report/000110465921098426-bourdow-carrie-l-2021-07-28 Nabriva Therapeutics plc 28 Jul 2021 2 $0 4 Director 30 Jul 2021, 20:20
TRVN TREVENA INC 28 Jun 2021 1 +$100,542 4 President & CEO, Director 28 Jun 2021, 17:33